| 9. Explanatory Notes (if any): | Consistent with footnote 348 in Release No. IC33836, to facilitate the transition to calculating fees on Form 24F2, the Fund has reduced the aggregate sales price of securities sold during the fiscal year reported in response to Item 5(i) by the amount of excess shares that were registered under the Funds last registration statement on Form N2 that remain unsold prior to the effectiveness of Rule 24f2 as applied to interval funds. Specifically, the Fund sold shares with an aggregate value of $976720000 during the period and had $2000000000 of shares that were registered under the last Form N2 and remained unsold prior to the effectiveness of the rule as applied to the Fund. |